(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LYBALVI

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

LYBALVI

ST13

US500000090765835

Class

35, 36, 44, 45

Filing

90765835

Registration

8111270

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

01/20/2026

Trademark type

Word

Nice classes

35, 36, 44, 45

Filing date

06/10/2021

Registration date

01/20/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/20/2026

Last transaction

01/20/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

01/21/2022

First use in commerce

02/23/2022

Drawing code

4

Owner type

03

Owner location

Dublin 4, IE

Examiner

MITTLER, KEVIN A

Law office

T10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Alkermes Pharma Ireland Limited

Representatives

Norm J. Rich FOLEY & LARDNER LLP

Technical classification

Nice Classes

Class 35Class 36Class 44Class 45

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Logistics management in the field of medicationbusiness services in the nature of supporting the coordination of medication delivery to avoid product delivery delays; providing business administration information to patients and health care providers about medication reimbursement options regarding reimbursement procedures; providing information about pharmaceutical servicesproviding information about pharmacy authorization in the nature of prescription fulfillment and approval instructions for delivery of medication in the nature of accepting payment terms

Class 36

Providing information about pharmaceutical coverage by patient health plans; providing insurance administration information to patients and health care providers about medication reimbursement options; insurance services being support services for patients and for health care providers on behalf of their patientsproviding health benefit verification services to determine coverage of medication treatment; financial administration of medication reimbursement programs being support services for patients and for health care providers on behalf of their patientscoordinating medication reimbursement programs

Class 44

Providing educational information in the field of medication treatment to health care providers and patients; providing educational information about the diagnosticprophylactictherapeutic properties of pharmaceuticals and pharmaceutical products for medical purposes

Class 45

Support services for health care providers and their patients in the nature of providing case management servicescoordinating the procurement of medication in the nature of conducting benefits verification with payers to facilitate prescription fulfilment and coordinating with non-commercial pharmacy to facilitate prescription fulfilment for patients eligible for patient assistance program; providing case management services in the nature of support services for patients and for health care providers on behalf of their patientscoordinating the procurement of medication in the nature of conducting benefits verification with payers to facilitate prescription fulfilment and coordinating with non-commercial pharmacy to facilitate prescription fulfilment for patients eligible for patient assistance program

Publications

History of USPTO decisions and trademark events.

37 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/20/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

01/20/2026

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

12/30/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

12/30/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/27/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

05/26/2023

EX1G

SOU EXTENSION 1 GRANTED

05/26/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

05/25/2023

EXT1

SOU EXTENSION 1 FILED

05/19/2023

IUAF

USE AMENDMENT FILED

05/19/2023

EEXT

SOU TEAS EXTENSION RECEIVED

05/19/2023

EISU

TEAS STATEMENT OF USE RECEIVED

05/19/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

11/29/2022

NEWN

NEW NOA TO ISSUE

10/17/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

07/28/2022

IUCN

NOTICE OF ALLOWANCE CANCELLED

07/26/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/31/2022

PUBO

PUBLISHED FOR OPPOSITION

05/31/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/11/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/26/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

04/26/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

04/26/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

04/26/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

04/26/2022

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

04/15/2022

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

03/29/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/14/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

03/14/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/14/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

03/14/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/14/2022

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

03/11/2022

PBMR

WITHDRAWN FROM PUB - MANAGING ATTORNEY REQUEST

03/11/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/07/2022

DOCK

ASSIGNED TO EXAMINER

03/01/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/30/2021

NWAP

NEW APPLICATION ENTERED

06/14/2021

Continuous trademark protection

Get notified about every new filing that threatens LYBALVI or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.